Rush Cancer Institute Univ. of Massachussets Medical Center — Worcester, Massachusetts

Rush Cancer Institute Univ. of Massachussets Medical Center is a clinical research site located in Worcester, Massachusetts, United States 01605.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Rush Cancer Institute Univ. of Massachussets Medical Center has participated in 1 clinical trials.

Therapeutic areas: Myelodysplastic Syndrome, Iron Overload.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush Cancer Institute Univ. of Massachussets Medical Center?

Rush Cancer Institute Univ. of Massachussets Medical Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush Cancer Institute Univ. of Massachussets Medical Center conducted?

Rush Cancer Institute Univ. of Massachussets Medical Center has 1 clinical trials on record. Their work covers Myelodysplastic Syndrome, Iron Overload.

Is Rush Cancer Institute Univ. of Massachussets Medical Center accredited by Crixeo Health?

Rush Cancer Institute Univ. of Massachussets Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rush Cancer Institute Univ. of Massachussets Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.